The Trump administration is ending a Medicare drug subsidy program. Here's how it could affect costs
The Trump administration has decided to end a Medicare drug subsidy program in 2027 that had been keeping prescription drug costs lower for seniors. This move could lead to higher monthly costs for millions of older adults with Medicare drug coverage, creating tension with the administration's stated goal of reducing drug prices.
51 across the spectrum. Choose a side on the bar to jump to it.
National story. 115 articles from 51 sources. Updated Aug 2, 2026.
Left
16 sourcesThe Trump administration is ending a Medicare drug subsidy program. Here’s how it could affect costs.
Medicare Part D subsidy program: Why Trump is ending it and what it could mean for prescription drug costs
The Trump administration's move to end subsidies for Medicare drug plans could cost consumers
Center
24 sourcesTrump administration is ending a Medicare drug subsidy program. Here's how it could affect costs
Right
11 sourcesTrump administration moves to end Biden-era Medicare Part D premium subsidies after 2026
Trump administration ending Biden-era temporary Medicare drug subsidy
What is Medicaid Part D, the subsidy program the Trump administration plans to end?
Trump administration is ending a Medicare drug subsidy program
The story so far
2 developments- Jul 29A Medicare Part D subsidy aimed at lowering prescription prices is coming to an end in 2027
- Jul 30The Trump administration is ending a Medicare drug subsidy program. Here’s how it could affect costs
Who covered each development
No new developments
Quiet for 80 daysLast development · Jul 30 — The Trump administration is ending a Medicare drug subsidy program. Here’s how it could affect costs